MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Randomized Clinical Trial of Immersive Virtual Reality and Cognitive Rehabilitation for Mild Cognitive Impairment in Parkinson’s Disease

A. Puig-Davi, A. Moreu-Valls, S. Martinez-Horta, G. Kulisevsky, J. Rodriguez-Antiguedad, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

Meeting: 2025 International Congress

Keywords: Cognitive dysfunction, Magnetic resonance imaging(MRI), Rehabilitation

Category: Parkinson’s Disease: Clinical Trials

Objective: To investigate the efficacy of Immersive Virtual Reality (IVR) and Computerized Cognitive Training (CCT) for mild cognitive impairment in Parkinson’s disease (PD-MCI)

Background: PD-MCI is a common non-motor feature of Parkinson’s disease with no established symptomatic treatments. Non-pharmacological interventions, such as cognitive training, are promising options for maintaining neural plasticity, enhancing cognition, and improving emotional well-being. However, high-quality studies are needed to confirm their efficacy

Method: We conducted a 24-week, single-center, randomized, single-blind clinical trial in people with PD-MCI. Participants were randomized into an executive function-focused IVR intervention (n = 19) or a multidomain CCT intervention (n = 17). A standard of care (SoC; n = 15) control group with no active intervention was also involved. Weekly 45-min sessions were conducted. Baseline and post-intervention assessments included measures of global cognition, functional, motor, neuropsychiatric symptoms, and digital metrics derived from the interventions, along with structural and functional neuroimaging

Results: IVR and CCT groups showed significant improvements in primary and secondary cognitive endpoints. Linear mixed-effects models showed that, compared to the SoC group, the IVR group experienced an improvement in the trajectory of the Parkinson’s Disease-Cognitive Rating Scale (PD-CRS) score (β = 8.13, SE = 2.88, p = 0.007), a decrease in cognitive-functional dependency measures (β = -3.16, SE = 1.39, p = 0.028) and apathy scores (β = -5.96, SE = 2.77, p = 0.038) at week 24. The CCT group demonstrated an improvement in the PD-CRS scores (β = 5.76, SE = 2.84, p = 0.049) and cognitive-functional dependency measures (β = -3.78, SE = 1.39, p = 0.009) at week 24 [Figure 1]

Conclusion: Both interventions significantly improved cognitive functions and everyday cognitive functionality in individuals with PD-MCI. Technology-based cognitive training offers a promising, adaptive, and personalized approach to managing cognitive decline in Parkinson’s disease

Figure 1

Figure 1

To cite this abstract in AMA style:

A. Puig-Davi, A. Moreu-Valls, S. Martinez-Horta, G. Kulisevsky, J. Rodriguez-Antiguedad, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky. A Randomized Clinical Trial of Immersive Virtual Reality and Cognitive Rehabilitation for Mild Cognitive Impairment in Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/a-randomized-clinical-trial-of-immersive-virtual-reality-and-cognitive-rehabilitation-for-mild-cognitive-impairment-in-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-randomized-clinical-trial-of-immersive-virtual-reality-and-cognitive-rehabilitation-for-mild-cognitive-impairment-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley